| Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
ADILW Adial Pharmaceuticals, Inc. WT EXP 073123
|
66.8 million |
- |
-
|
- |
- |
-
|
|
AHPAW Avista Public Acquisition Corp. II
|
229.3 million |
- |
-
|
- |
- |
-
|
|
AIQ Global X Artificial Intelligenc
|
1.1 billion |
0.00% |
41.81
|
2 |
7 |
-10%
|
|
AKRX Akorn, Inc.
|
12.0 million |
0.00% |
-0.03
|
- |
- |
-
|
|
APOPW Cellect Biotechnology Ltd.
|
14.3 million |
- |
-
|
- |
- |
-
|
|
ASEI 84989
|
- |
0.00% |
633
|
- |
- |
-
|
|
AXGT Axovant Gene Therapies Ltd.
|
88.1 million |
- |
-1.09
|
- |
- |
-
|
|
BDXA Becton, Dickinson and Company
|
64.6 billion |
5.12% |
21.44
|
3 |
- |
-
|
|
BNTCW Benitec Biopharma Limited
|
9.0 million |
- |
-
|
- |
- |
-
|
|
CELG Celgene Corp.
|
77.0 billion |
0.00% |
12.98
|
- |
- |
-
|
|
CHEKZ Check-Cap Ltd
|
84.9 million |
- |
-
|
- |
- |
-
|
|
CTXRW Citius Pharmaceuticals, Inc.
|
256.9 million |
- |
-
|
- |
- |
-
|
|
CYRXW CryoPort, Inc.
|
568.9 million |
- |
-
|
- |
- |
-
|
|
CYTX Cytori Therapeutics, Inc.
|
4.6 million |
- |
-0.14
|
- |
- |
-
|
|
DSCO 484176
|
- |
- |
-
|
- |
- |
-
|
|
ELAT Elanco Animal Health Incorporat
|
15.6 billion |
4.90% |
-
|
3 |
4 |
-
|
|
ELGX Endologix, Inc.
|
4.2 million |
- |
-0.09
|
- |
- |
-
|
|
ENTXW Entera Bio Ltd. WT EXP 062723
|
84.3 million |
- |
-
|
- |
- |
-
|
|
EYEGW EyeGate Pharmaceuticals, Inc.
|
60148 |
- |
-
|
- |
- |
-
|
|
EYESW Second Sight Medical Products Inc
|
107.2 million |
- |
-
|
- |
- |
-
|
|
HJLIW Hancock Jaffe Laboratories, Inc
|
90.1 million |
- |
-
|
- |
- |
-
|
|
HSGX Histogenics Corp.
|
15.3 million |
- |
0.84
|
- |
- |
-
|
|
IMACW IMAC Holdings, Inc.
|
3.5 million |
- |
-
|
- |
- |
-
|
|
IMRNW Immuron Ltd
|
20.6 million |
- |
-
|
- |
- |
-
|
|
MDGSW Medigus Ltd. WT C EXP 072323
|
28.0 million |
- |
-
|
- |
- |
-
|
|
MNLO Menlo Therapeutics Inc.
|
82.5 million |
- |
-0.41
|
- |
- |
-
|
|
MTFBW Motif Bio Plc
|
- |
- |
-
|
- |
- |
-
|
|
NDRAW ENDRA Life Sciences Inc.
|
49.0 million |
- |
-
|
- |
- |
-
|
|
ONSIZ Oncobiologics Inc. Series B Warrant
|
- |
- |
-
|
- |
- |
-
|
|
ONTXW Onconova Therapeutics, Inc.
|
80.8 million |
- |
-
|
- |
- |
-
|
|
OTLKW Outlook Therapeutics, Inc. - Se
|
333.1 million |
- |
-
|
- |
- |
-
|
|
PTLA Portola Pharmaceuticals, Inc.
|
1.4 billion |
1.37% |
-4.77
|
- |
- |
-
|
|
SKBI Skystar Bio-Pharmaceutical Co.
|
15.6 million |
- |
-
|
- |
- |
-
|
|
SNGXW Soligenix, Inc.
|
36.0 million |
- |
-
|
- |
- |
-
|
|
SPAN 1922
|
- |
2.13% |
16.48
|
- |
- |
-
|
|
TEAR TearLab Corporation
|
1.4 million |
- |
-0.05
|
- |
- |
-
|
|
THLD 43225
|
- |
4.05% |
18.97
|
- |
- |
-
|
|
TTPH Tetraphase Pharmaceuticals, Inc
|
16.1 million |
- |
-0.13
|
- |
- |
-
|
|
VRX 775650
|
8.2 billion |
0.00% |
5.91
|
- |
- |
-
|
|
VSCI 15565
|
- |
- |
-
|
- |
- |
-
|
|
VVUS VIVUS, Inc.
|
8.3 million |
3.17% |
-0.23
|
- |
- |
-
|
|
XBIOW Xenetic Biosciences, Inc.
|
5.6 million |
- |
-
|
- |
- |
-
|
|
XON Intrexon Corp.
|
756.5 million |
- |
-1.30
|
- |
- |
-
|